JPS61158783A - ヒトの腫瘍白血病ウイルス３のソラレンによる不活化 - Google Patents

ヒトの腫瘍白血病ウイルス３のソラレンによる不活化

Info

Publication number
JPS61158783A
JPS61158783A JP60246443A JP24644385A JPS61158783A JP S61158783 A JPS61158783 A JP S61158783A JP 60246443 A JP60246443 A JP 60246443A JP 24644385 A JP24644385 A JP 24644385A JP S61158783 A JPS61158783 A JP S61158783A
Authority
JP
Japan
Prior art keywords
inactivation
virus
htlv
psoralen
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP60246443A
Other languages
English (en)
Japanese (ja)
Inventor
カール・ベイス・ハンソン
ステイーブン・バートン・ランバート
ジエイムズ・カールトン・リチヤーズ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EIDP Inc
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Publication of JPS61158783A publication Critical patent/JPS61158783A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet [UV] radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15061—Methods of inactivation or attenuation
    • C12N2740/15063—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP60246443A 1984-11-05 1985-11-05 ヒトの腫瘍白血病ウイルス３のソラレンによる不活化 Pending JPS61158783A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66844284A 1984-11-05 1984-11-05
US668442 1984-11-05

Publications (1)

Publication Number Publication Date
JPS61158783A true JPS61158783A (ja) 1986-07-18

Family

ID=24682332

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60246443A Pending JPS61158783A (ja) 1984-11-05 1985-11-05 ヒトの腫瘍白血病ウイルス３のソラレンによる不活化

Country Status (4)

Country Link
EP (1) EP0184331A3 (enExample)
JP (1) JPS61158783A (enExample)
DK (1) DK507185A (enExample)
GR (1) GR852669B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009504690A (ja) * 2005-08-18 2009-02-05 ゲンマブ エー／エス Ｃｄ４結合ペプチドおよび放射線による治療

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0602761A1 (en) * 1987-06-10 1994-06-22 The Immune Response Corporation, Inc. Prevention and treatment of retroviral disease
IL92996A (en) * 1989-01-10 1996-06-18 Bisaccia Emil Photoactive compounds as medicaments for the treatment of virus infections and method for production of vaccines
EP0544895B1 (en) * 1991-06-21 1997-08-27 Baxter International Inc. Method for inactivating pathogens in a body fluid
AU4677993A (en) * 1992-08-07 1994-03-03 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US5288605A (en) * 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
US7498156B2 (en) 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US7049110B2 (en) 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US6565802B1 (en) 1999-06-03 2003-05-20 Baxter International Inc. Apparatus, systems and methods for processing and treating a biological fluid with light
US7068361B2 (en) 1999-06-03 2006-06-27 Baxter International Apparatus, systems and methods for processing and treating a biological fluid with light
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568542A (en) * 1981-06-09 1986-02-04 Lee Biomolecular Research Laboratories, Inc. Vaccine compositions
DE3483751D1 (de) * 1983-05-02 1991-01-31 Diamond Scient Co Photochemische entkeimungsbehandlung von vollem blut oder blutbestandteilen.
US4545987A (en) * 1983-12-20 1985-10-08 Advanced Genetics Research Institute Psoralen inactivated double-stranded RNA viral vaccines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009504690A (ja) * 2005-08-18 2009-02-05 ゲンマブ エー／エス Ｃｄ４結合ペプチドおよび放射線による治療

Also Published As

Publication number Publication date
DK507185D0 (da) 1985-11-04
EP0184331A3 (en) 1987-08-26
DK507185A (da) 1986-05-06
EP0184331A2 (en) 1986-06-11
GR852669B (enExample) 1986-03-05

Similar Documents

Publication Publication Date Title
Lambrecht et al. Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light
JPS61275228A (ja) 治療用タンパク組成物中のビ−ルスの光動的不活性化
Kitchen et al. Effect of gamma irradiation on the human immunodeficiency virus and human coagulation proteins
JPS61158783A (ja) ヒトの腫瘍白血病ウイルス３のソラレンによる不活化
US6617157B1 (en) Methods and compositions for the selective modification of nucleic acids
Huang et al. Defective T particles of vesicular stomatitis virus: II. Biologic role in homologous interference
Henle et al. Cytolytic effects of mumps virus in tissue cultures of epithelial cells.
JP5675690B2 (ja) ホルマリンおよびｕｖ光での処理によるサンプル中の病原体の不活化
Smetana et al. Photodynamic inactivation of herpes viruses with phthalocyanine derivatives
Croughan et al. Comparative study of inactivation of herpes simplex virus types 1 and 2 by commonly used antiseptic agents
Friesen et al. Some physicochemical and immunological properties of an avian leucosis virus (RIF)
US6165711A (en) Process for disintegrating nucleic acids and preparing biological products of guaranteed quality
US8703467B2 (en) Inactivation of a pathogen in a sample by a treatment with formalin and UV light
Sofer Virus Inactivation in the 1990s—and into the 21st Century
US20120270292A1 (en) Photo-Inactivated Viruses and Systems and Methods of Using the Same
WO1986004613A1 (en) A method for detecting htlv-iii neutralizing antibodies in sera
US6352695B1 (en) Methods and compositions for the selective modification of nucleic acids
Wiktor et al. Immunogenicity of rabies virus inactivated by β-propiolactone, acetylethyleneimine, and ionizing irradiation
Ushimi et al. Study of the one-step growth curve of equine infectious anemia virus by immunofluorescence
Deshmukh et al. Ultraviolet inactivation and photoreactivation of avian viruses
Liebhaber et al. STUDIES OF A MYXOVIRUS RECOVERED FROM PATIENTS WITH INFECTIOUS HEPATITIS: I. ISOLATION AND CHARACTERIZATION
Siegel et al. Action spectra for two strains of tobacco mosaic virus
Kato et al. Production of a viral growth enhancing factor (enhancer) in eggs infected with influenza virus (PR8)
Booth et al. Photodynamic inactivation of rubella virus
US3076748A (en) Poliomyelitis virus attenuation with ultraviolet light and beta propiolactone